Clinical epidemiology and evidence based medicine

Wes Onland graduated as a medical doctor in 1999 and started his official pediatric training in 2002 at the Emma Children’s Hospital of the Academic Medical Center (AMC) in Amsterdam (head: Prof. Dr. H.S.A. Heijmans), of which he spent one year at the Children’s Hospital Los Angeles for research (supervisor: Dr. W.Y. Wong). He subspecialized in Neonatology (head: Prof. dr. J.H. Kok). During this same period, he wrote his thesis (supervisors: Prof. dr. M. Offringa and Prof. dr. A. van Kaam) entitled: “Bronchopulmonary Dysplasia and Perinatal Glucocorticoids in Preterm Infants: Changing practice based on evidence”. He is participating in multiple (inter)national multicentre trials and is co-PI of the SToP-BPD (Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants) trial. He is currently working as medical staff member at the department of Neonatology in the Emma Children’s Hospital Amsterdam UMC in Amsterdam and is chair of the Neonatology Network Netherlands (N3) since 2018, the national organisation initiating, facilitating and organizing neonatal research, benchmarking and guideline developments (www.neonatologynetwork.eu).